DuraSeal Dural Sealant System
Integra LifeSciences Corporation · Decision date Dec 17, 2025
What did the FDA decide?
FDA records P040034/S040 as a supplement to PMA P040034, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 17, 2025.
FDA approval order statement
addition of an external supplier for in-process PBS solution
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Dec 17, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P040034/S040
- Regulatory pathway
- PMA supplement
- Applicant
- Integra LifeSciences Corporation
- Product code
- NQR
- Decision code
- OK30
- Decision date
- Dec 17, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sealant, dural.
- Applicant
- Integra LifeSciences Corporation
- Product code
- NQR
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P040034/S040 received
Application receipt date recorded by FDA.
P040034/S040 · FDA decision
30-Day Notice
P040034/S041 · Related supplement
DuraSeal Dural Sealant System
Timeline entries are records held by MedtechLedger for P040034. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P040034
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
DuraSeal Dural Sealant SystemP040034/S041 | Integra LifeSciences Corporation | PMA supplement | Feb 27, 2026 | FDA |
Explore the linked device profile
Other records with product code NQR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CraniSeal Dural SealantP220014/S013 | Pramand, LLC | PMA supplement | Oct 1, 2026 | FDA |
SpineSeal Spine SealantP240027/S007 | Pramand, LLC | PMA supplement | Sep 11, 2026 | FDA |
SpineSeal Spine SealantP240027/S006 | Pramand, LLC | PMA supplement | Aug 31, 2026 | FDA |
CraniSeal Dural SealantP220014/S012 | Pramand, LLC | PMA supplement | Aug 5, 2026 | FDA |
| Stryker Leibinger GmbH & Co. KG | PMA supplement | Jul 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Integra LifeSciences Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 311 Enterprise Dr., Planisboro, NJ, 08536
Sources and methodology
- Original FDA record: P040034/S040
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


